Hazel Lote
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Cancer Risks and Factors
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
-
- Gastric Cancer Management and Outcomes
- Renal cell carcinoma treatment
Papers in
- Oncology 9
- Cancer Immunotherapy and Biomarkers 3
- HER2/EGFR in Cancer Research 3
- Colorectal Cancer Treatments and Studies 2
-
- Gastric Cancer Management and Outcomes 4
- Co-authors
- Ian Chau (8 shared papers)Stefania Redana (2 shared papers)Marta Capelán (2 shared papers)Adam Sharp (2 shared papers)Marco Gerlinger (1 shared paper)Vejay N. Vakharia (1 shared paper)Naureen Starling (4 shared papers)Rille Pihlak (1 shared paper)
- Journals
- Annals of Oncology (2 papers)Cancer Treatment Reviews (2 papers)Journal of Clinical Oncology (1 paper)Clinical Oncology (1 paper)Radiology (1 paper)
- Partner nations
- United KingdomItalySpain
In The Last Decade
Hazel Lote
16 papers receiving 198 citations
Peers
Comparison fields: 5 of 43
- Oncology 103
- Pulmonary and Respiratory Medicine 47
- Urology 6
- Gastroenterology 5
- Immunology 20
Countries citing papers authored by Hazel Lote
This map shows the geographic impact of Hazel Lote's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hazel Lote with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hazel Lote more than expected).
Fields of papers citing papers by Hazel Lote
This network shows the impact of papers produced by Hazel Lote. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hazel Lote. The network helps show where Hazel Lote may publish in the future.
Co-authors
The 25 scholars most cited alongside Hazel Lote, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 60 | |
| 2 | 2014 | 28 | |
| 3 | 2016 | 25 | |
| 4 | 2022 | 19 | |
| 5 | 2016 | 11 | |
| 6 | 2012 | 9 | |
| 7 | 2018 | 9 | |
| 8 | 2014 | 8 | |
| 9 | 2013 | 7 | |
| 10 | 2013 | 7 | |
| 11 | 2022 | 7 | |
| 12 | 2020 | 4 | |
| 13 | 2024 | 3 | |
| 14 | 2023 | 2 | |
| 15 | 2016 | 1 | |
| 16 | 2016 | 1 | |
| 17 | 2023 | 0 |
About Hazel Lote
Hazel Lote is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Cancer Research and Molecular Biology, having authored 17 papers that have together received 201 indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Colorectal and Anal Carcinomas (3 papers), HER2/EGFR in Cancer Research (3 papers), Colorectal Cancer Treatments and Studies (2 papers), Urologic and reproductive health conditions (2 papers), MicroRNA in disease regulation (2 papers) and Genetic factors in colorectal cancer (2 papers). The work is most often cited by research in Oncology (103 citations), Pulmonary and Respiratory Medicine (47 citations), Urology (6 citations), Gastroenterology (5 citations) and Immunology (20 citations). Hazel Lote has collaborated with scholars based in United Kingdom, Italy and Spain. Frequent co-authors include Ian Chau, Stefania Redana, Marta Capelán, Adam Sharp, Marco Gerlinger, Vejay N. Vakharia, Naureen Starling, Rille Pihlak, Alexander Ring and Andreas Gutzeit. Their work appears in journals such as Annals of Oncology, Cancer Treatment Reviews, Journal of Clinical Oncology, Clinical Oncology and Radiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.